BRAF and melanoma: Most cell lines expressed LOXL3 independently of their mutational status, as we previously described [38], while BRAFV600E-mutated melanoma cells expressed elevated levels of LOXL3, SNAIL1, and PRRX1, the genes for which were significantly upregulated in BRAF-mutated patients ́ samples.